ACHV
Achieve Life Sciences, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Achieve Life Sciences, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No other changes.
No other changes.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
No thesis.
Annual filing, covered
10-K parsed · Mar 24 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 24 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Same SIC code · 6
Same SEC industry code: Idexx Laboratories Inc, Lantheus Holdings, Inc., Celldex Therapeutics, Inc. and 3 more; no measured co-movers for Achieve Life Sciences, Inc..
Same SIC code · 6
Same SEC industry code: Idexx Laboratories Inc, Lantheus Holdings, Inc., Celldex Therapeutics, Inc. and 3 more; no measured co-movers for Achieve Life Sciences, Inc..
Achieve Life Sciences, Inc.
7.01
+0.28 · +4.09%
Tall tick = annual report · Source: EDGAR
Largest filed tie
—
—
—
| Manager | Value | % base | |
|---|---|---|---|
| Frazier Life Sciences | $49.7M | 8.98% | new |
| TPG GP A | $44.9M | 8.11% | new |
| venBio Partners | $38.6M | 6.98% | new |
| Logos Global | $35.4M | 6.40% | new |
| BlackRockindex-like | $34.4M | 6.22% | +1099.93% |
| Manager | Value | % base | |
|---|---|---|---|
| Frazier Life Sciences | $49.7M | 8.98% | new |
| TPG GP A | $44.9M | 8.11% | new |
| venBio Partners | $38.6M | 6.98% | new |
| Logos Global | $35.4M | 6.40% | new |
| BlackRockindex-like | $34.4M | 6.22% | +1099.93% |
Bull3
Bear1
Expected move
Inputsstraddle ±31.3%
spot 6.73exp Nov 20ATM strike 7.5ATM straddle 2.47IV 197%